[Client Reminder] October 15 Deadline: Medicare Part D Notice of Creditable (or Non-Creditable Coverage)

Medicare Part D notices (of either creditable or non-creditable coverage) are due for distribution prior to October 15th.

Under the Medicare Modernization Act of 2003, employers who offer prescription drug coverage to any Medicare Part D eligible individuals must notify those individuals whether the offered prescription drug coverage is creditable coverage, meaning whether the coverage is expected to pay on average as much as the standard Medicare prescription drug coverage. Medicare Part D eligible individuals may include active employees, COBRA beneficiaries, retirees, and any of their spouses and dependents. This requirement is applicable to all employers, regardless of size or funding mechanism.

Due to the difficulty in ascertaining what all spouses, dependents, employees, retirees and COBRA beneficiaries may be entitled to Medicare based on age, disability or ESRD, many employers find it easiest to provide a blanket notice of creditable (or non-creditable) coverage to all individuals who are offered the employer’s prescription drug coverage. Medicare Part D notices must be provided to Medicare-eligible individuals prior to October 15th of each year.

The initial notices were due by November 15, 2005 and have been modified numerous times. The newest model notices and guidance were issued for use after April 1, 2011. Therefore, any notices sent from this point forward must conform to the new guidelines. Use of the former model notices will not suffice.

Downloads to the updated guidance (including links on how to determine creditable coverage status) can be found on the CMS website HERE. Downloads to the updated Creditable Coverage Notice and Non-Creditable Coverage Notice (both in English and Spanish) can be found on the CMS website HERE.

As a reminder, there are five instances in which such notice must be provided:

  1. Prior to an individual’s initial enrollment period for Part D;
  2. Prior to the effective date of enrollment in the employer’s prescription drug coverage;
  3. Upon any change in the plan’s creditable status;
  4. Prior to the annual election period for Part D (which begins each October 15); and
  5. Upon the individual’s request.

Providing the notice above is important as a late enrollment penalty will be assessed to those persons who go 63 days or longer without creditable coverage (for example, if they enroll in an employer’s prescription plan which is not as valuable as the Part D coverage instead of enrolling directly in the Medicare Part D coverage).

If the employer’s plan does not offer creditable prescription drug coverage and if the Part D eligible person enrolls in that plan instead of the Part D plan for at least 63 days, a permanent late enrollment penalty of 1% of the premium is added to the Medicare premium for each month the person does not enroll in Part D.

Please contact us if assistance is needed with the Notices of Creditable (or Non-Creditable) Coverage or with questions regarding the method of distribution.

Reminder: Submit Medicare Part D Notice to CMS

As discussed above, group health plans offering prescription drug coverage are required to disclose to all Part D-eligible individuals who are enrolled in or were seeking to enroll in the group health plan coverage whether such coverage was “actuarially equivalent”, i.e., creditable.

The regulations also require group health plan sponsors with Part D eligible individuals to submit a similar notice to the Centers for Medicare and Medicaid Services (“CMS”). Specifically, employers must electronically file these notices each year through the form supplied on the CMS website.

The filing deadline is 60 days following the first day of the plan year.

At a minimum, the Disclosure to CMS Form must be provided to CMS annually and upon the occurrence of certain other events including:

  1. Within 60 days after the beginning date of the plan year for which disclosure is provided;
  2. Within 30 days after termination of the prescription drug plan; and
  3. Within 30 days after any change in creditable status of the prescription drug plan.

The Disclosure to CMS Form must be completed online at the CMS Creditable Coverage Disclosure to CMS Form web page HERE.

The online process is composed of the following three steps:

  1. Enter the Disclosure Information;
  2. Verify and Submit Disclosure Information; and
  3. Receive Submission Confirmation.

The Disclosure to CMS Form requires employers to provide detailed information to CMS including but not limited to, the name of the entity offering coverage, whether the entity has an subsidiaries, the number of benefit options offered, the creditable coverage status of the options offered, the period coverage by the Disclosure to CMS Form, the number of Part D eligible individuals, the date of the notice of creditable coverage, and any change in creditable status.

For more information about this disclosure requirement (instructions for submitting the notice), please see the CMS website for updated guidance HERE.

As with the Part D Notices to Part D Medicare-eligible individuals, while nothing in the regulations prevents a third-party from submitting the notices (such as a TPA or insurer), the ultimate responsibility falls on the plan sponsor.


Elizabeth H. Latchana, Attorney Fraser TrebilcockElizabeth H. Latchana specializes in employee health and welfare benefits. Recognized for her outstanding legal work, in both 2018 and 2015, Beth was selected as “Lawyer of the Year” in Lansing for Employee Benefits (ERISA) Law by Best Lawyers, and in 2017 as one of the Top 30 “Women in the Law” by Michigan Lawyers Weekly. Contact her for more information on this reminder or other matters at 517.377.0826 or elatchana@fraserlawfirm.com.

Client Alert: CMS Issues Final Rule on Reporting and Return of Overpayments Under 60-Day Rule

Health Care Law

On February 12, 2016, the Centers for Medicare & Medicaid Services (“CMS”) published a long-awaited Final Rule regarding Section 6402(a) of the Affordable Care Act—the so-called “60-day rule”. The 60-day rule outlines the obligation of providers and suppliers to report and return Medicare overpayments within 60 days of their “identification”. A provider or supplier who retains Medicare overpayments beyond the 60-day period faces the risk of False Claims Act (FCA) liability, Civil Monetary Penalties Law (CMPL) liability, and exclusion from federal health care programs.

Section 6402(a) of the Affordable Care Act added section 1128J(d) to the Social Security Act (“the Act”). Section 1128J(d) of the Act requires a Medicare or Medicaid provider or supplier to return and report an overpayment “by the later of: (A) the date which is 60 days after the date on which the overpayment was identified; or (B) the date any  corresponding cost report is due, if applicable”.

Since Section 6402(a) of the ACA was enacted in 2010, there has been confusion about what it means to identify an overpayment for the purposes of starting the 60-day clock, how far back a provider or supplier must look back to identify an overpayment, and the obligations a provider or supplier has once it has identified an overpayment.

Under the Final Rule, the 60-day clock starts when a provider or supplier has identified an overpayment and defines “identified” as occurring when “the person has or should have, through the exercise of reasonable diligence, determined that the person has received an overpayment and quantified the amount of the overpayment. A person should have determined that the person received an overpayment if the person fails to exercise diligence and the person in fact received an overpayment”. CMS clarified in the Final Rule that the 60-day time period does not begin to run until after the reasonable diligence period is completed, and agreed with commentators that “part of identification is quantifying the amount, which requires a reasonably diligent investigation”.

The CMS also clarified that reasonable diligence means a timely, good faith investigation of credible information, which should take no longer than six months from the receipt of credible information, except under extraordinary circumstances.

The Final Rule recognizes that providers and suppliers must exercise reasonable diligence by being both proactive and reactive. Proactive reasonable diligence includes implementing compliance activities, conducted in good faith by qualified individuals, to monitor for the receipt of overpayments. Reactive reasonable diligence would include having qualified individuals undertaking investigations in a timely manner “in response to obtaining credible information of a potential overpayment”.

Providers and suppliers should understand that failure to initiate reasonable diligence efforts could start the running of the 60-day clock on the day the provider or supplier received credible information of a potential overpayment. Providers and suppliers should also recognize that failure to initiate reasonable diligence efforts with all deliberate speed after obtaining overpayment information could result in knowingly retaining an overpayment because the provider or supplier “acted in reckless disregard or deliberate ignorance of whether it received an overpayment”.

Under the Final Rule, the CMS finalized a 6-year lookback period rather than the 10-year lookback originally suggested by the Proposed Rule. Under the Final Rule, providers and suppliers must report and return overpayments identified “within 6 years of the date the overpayment was received”.

Other important provisions of the Final Rule:

Overpayments caused by errors or third parties outside of the provider’s or supplier’s control, including CMS system errors, are also subject to the 60-day time period.  Therefore, providers and suppliers will need to ensure implemented compliance activities also monitor for overpayment errors from third parties outside the provider’s or supplier’s control.

To satisfy the obligation to report and return overpayments under the final rule, a provider or supplier must use “an applicable claims adjustment, credit balance, self-reported refund, or another appropriate process” to report and return overpayments.

The final rule goes into effect March 14, 2016, and applies to Medicare Part A and Part B provider and suppliers. An earlier Final Rule, published in May 2014 applies to overpayments under Medicare Parts C and D. No final rules has been published that addresses requirements for Medicaid and some states are developing their own requirements.

To find out more about the Final Rule from CMS and its impact on health care and your business, contact Fraser Trebilcock at 517.482.5800.

Medicare Part D Notice Deadline Approaching

Group health plans offering prescription drug coverage are required to disclose to all Part D-eligible individuals who are enrolled in or were seeking to enroll in the group health plan coverage whether such coverage was “actuarially equivalent,” I.e., creditable. (Coverage is creditable if its actuarial value equals or exceeds the actuarial value of standard prescription drug coverage under Part D.) This notice is required to be provided to all Part D eligible persons, including active employees, retirees, spouses, dependents and COBRA qualified beneficiaries.

Continue reading Medicare Part D Notice Deadline Approaching